臨床パラメータを用いた結核患者における薬剤師の介入による利益の機械学習予測:単一センターの遡及研究
Tingting Li1, Huanqing Liu2, Zhuhong You3
1Drug Clinical Trial Institution Office, Xi'an Chest Hospital, Xi'an, Shaanxi, China.
Frontiers in cellular and infection microbiology
|February 20, 2026
まとめ
機械学習は,どの結核患者が薬剤師の介入から利益を得るか正確に予測し,治療リソースの割り当てを改善します. このモデルは,結核患者に対するパーソナライズされたケアを強化します.
科学分野:
- *医療における機械学習の応用
- * 臨床情報学と予測モデリング
背景:
- *結核 (TB) は,世界的な健康上の重大な負担であり,効率的な患者管理を必要とします.
- * 薬剤師による介入のための患者を特定することは,結果とリソースの割り当てを最適化するために極めて重要です.
- *臨床パラメータを用いた予測モデリングは,結核患者に対する薬剤師による標的型介入に役立つ.
研究 の 目的:
- *入院時に結核患者の薬剤師による介入グループ割り当てを予測するための機械学習モデルを開発・検証.
- *高度な機能エンジニアリングとハイパーパラメータチューニングを使用してモデルを最適化します.
- * 文脈的理解のためのトランスクリプトミックのデータ分析を通じて生物学的洞察を探求する.
主な方法:
- *467人の結核患者の遡及分析.
- *データ増強技術 (複数隣接インターポレーション) で,データセットのサイズを1,999個のサンプルに拡大します.
- * 多層アンサンブルモデル (43ベースモデル) のための広範な機能エンジニアリング (122機能) とOptunaベースのハイパーパラメータ最適化.
主要な成果:
- *アンサンブルモデルは,薬剤師の介入グループ割り当てを予測する際に92.25%の正確性と96.96%のAUC-ROCを達成しました.
- *GEOデータセットのトランスクリプトミックの分析により,150の異なる発現遺伝子と,免疫/炎症経路が強化されたことが判明しました.
結論:
- * 機械学習の最適化は,結核治療における薬剤師による介入に対する患者の適格性を効果的に予測します.
- * 臨床的変数のみに基づいた臨床予測モデルは,個別化された結核治療資源配置のための強力なツールを提供します.
- * 高い予測精度は,患者の管理を改善するために臨床実施の可能性を示唆しています.
キーワード:
臨床的予測を予測する.アンサンブル・ラーニングとはアンサンブル・ラーニングのことです.機械学習 (Machine Learning) とは,機械学習 (Machine Learning) とは,機械学習 (Machine Learning) と呼ばれるものです.薬剤師による介入は,薬剤師による介入です.資源の配分 資源の配分結核 (結核病) とはさらに関連する動画
関連する概念動画
Pulmonary Tuberculosis V
660
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
660
Pulmonary Tuberculosis IV
559
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
559
Pulmonary Tuberculosis I
1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis II
1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
25
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
25
Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K


